• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors.

作者信息

Brooks B R

机构信息

ALS Clinical Research Center, University of Wisconsin Hospital and Clinics, Clinical Science Center, Madison 53792-5132.

出版信息

J Neurol Sci. 1994 Jul;124 Suppl:96-107. doi: 10.1016/0022-510x(94)90191-0.

DOI:10.1016/0022-510x(94)90191-0
PMID:7807156
Abstract
摘要

相似文献

1
El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors.世界神经病学联合会埃斯科里亚尔肌萎缩侧索硬化诊断标准。世界神经病学联合会神经肌肉疾病研究组运动神经元疾病/肌萎缩侧索硬化小组委员会以及埃斯科里亚尔“肌萎缩侧索硬化的临床界限”研讨会参与者。
J Neurol Sci. 1994 Jul;124 Suppl:96-107. doi: 10.1016/0022-510x(94)90191-0.
2
Clinical neurophysiology in the diagnosis of amyotrophic lateral sclerosis: the Lambert and the El Escorial criteria.临床神经生理学在肌萎缩侧索硬化症诊断中的应用：兰伯特标准与埃尔埃斯科里亚尔标准
J Neurol Sci. 1998 Oct;160 Suppl 1:S25-9. doi: 10.1016/s0022-510x(98)00194-4.
3
[What are the clinical criteria of amyotrophic lateral sclerosis by clinical form?].[肌萎缩侧索硬化症按临床类型划分的临床标准是什么？]
Rev Neurol (Paris). 2006 Jun;162 Spec No 2:4S25-4S28.
4
World Federation of Neurology Research Group on Neuromuscular Diseases Subcommittee on Motor Neuron Disease. Airlie House guidelines. Therapeutic trials in amyotrophic lateral sclerosis. Airlie House "Therapeutic Trials in ALS" Workshop Contributors.世界神经病学联合会神经肌肉疾病研究小组运动神经元病小组委员会。艾丽屋指南。肌萎缩侧索硬化症的治疗试验。艾丽屋“肌萎缩侧索硬化症治疗试验”研讨会参与者。
J Neurol Sci. 1995 May;129 Suppl:1-10.
5
The El Escorial criteria: strengths and weaknesses.埃斯科里亚尔标准：优点与不足
Amyotroph Lateral Scler Frontotemporal Degener. 2015 Mar;16(1-2):1-7. doi: 10.3109/21678421.2014.964258. Epub 2014 Dec 8.
6
Getting the diagnosis right: beyond El Escorial.正确诊断：超越埃斯科里亚尔标准。
J Neurol. 1999 Nov;246 Suppl 3:III10-2. doi: 10.1007/BF03161083.
7
Amyotrophic lateral sclerosis: considerations on diagnostic criteria.肌萎缩侧索硬化症：关于诊断标准的考量
Arq Neuropsiquiatr. 2010 Dec;68(6):837-42. doi: 10.1590/s0004-282x2010000600002.
8
ALS diagnostic criteria of El Escorial Revisited: do they meet the needs of clinicians as well as researchers?再探埃斯科里亚尔肌萎缩侧索硬化症诊断标准：它们是否满足临床医生和研究人员的需求？
Amyotroph Lateral Scler Other Motor Neuron Disord. 2000 Mar;1 Suppl 1:S57-60. doi: 10.1080/14660820052415925.
9
Reliability of the El Escorial diagnostic criteria for amyotrophic lateral sclerosis.肌萎缩侧索硬化症的埃尔埃斯科里亚尔诊断标准的可靠性。
Neuroepidemiology. 2002 Nov-Dec;21(6):265-70. doi: 10.1159/000065524.
10
The role of cranial and thoracic electromyography within diagnostic criteria for amyotrophic lateral sclerosis.颅部和胸部肌电图在肌萎缩侧索硬化诊断标准中的作用。
Muscle Nerve. 2016 Sep;54(3):378-85. doi: 10.1002/mus.25062. Epub 2016 Jun 9.

引用本文的文献

1
Trimeric superoxide dismutase 1 antibody as a universal biomarker for ALS.三聚体超氧化物歧化酶1抗体作为肌萎缩侧索硬化症的通用生物标志物。
Res Sq. 2025 Jul 15:rs.3.rs-6941118. doi: 10.21203/rs.3.rs-6941118/v1.
2
Mutations in NEK1 cause ciliary dysfunction as a novel pathogenic mechanism in amyotrophic lateral sclerosis.NEK1基因的突变导致纤毛功能障碍，这是肌萎缩侧索硬化症的一种新的致病机制。
Mol Neurodegener. 2025 May 20;20(1):59. doi: 10.1186/s13024-025-00848-7.
3
Specific Bacterial Taxa and Their Metabolite, DHPS, May Be Linked to Gut Dyshomeostasis in Patients with Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis.
特定细菌分类群及其代谢产物二氢蝶酸合酶（DHPS）可能与阿尔茨海默病、帕金森病和肌萎缩侧索硬化症患者的肠道生态失调有关。
Nutrients. 2025 May 6;17(9):1597. doi: 10.3390/nu17091597.
4
Phosphatemia is an Independent Prognostic Factor in Amyotrophic Lateral Sclerosis.血磷水平是肌萎缩侧索硬化症的独立预后因素。
Ann Neurol. 2025 Apr 26. doi: 10.1002/ana.27252.
5
Deciphering distinct genetic risk factors for FTLD-TDP pathological subtypes via whole-genome sequencing.通过全基因组测序解析额颞叶痴呆-嗜银颗粒蛋白病（FTLD-TDP）病理亚型的不同遗传风险因素。
Nat Commun. 2025 Apr 25;16(1):3914. doi: 10.1038/s41467-025-59216-0.
6
Autonomic nervous system and mediating role of respiratory function in patients with ALS.肌萎缩侧索硬化症患者的自主神经系统及呼吸功能的介导作用
Sci Rep. 2025 Mar 27;15(1):10513. doi: 10.1038/s41598-025-94844-y.
7
Clinical and Imaging Features of Sporadic and Genetic Frontotemporal Lobar Degeneration TDP-43 A and B.散发性和遗传性额颞叶痴呆TDP-43 A型和B型的临床及影像学特征
Ann Clin Transl Neurol. 2025 May;12(5):947-957. doi: 10.1002/acn3.70014. Epub 2025 Mar 10.
8
T1-relaxation times along the corticospinal tract as a diagnostic marker in patients with amyotrophic lateral sclerosis.作为肌萎缩侧索硬化症患者诊断标志物的沿皮质脊髓束的T1弛豫时间
Front Neuroimaging. 2025 Feb 13;4:1549727. doi: 10.3389/fnimg.2025.1549727. eCollection 2025.
9
Head Injury and Amyotrophic Lateral Sclerosis: Population-Based Study from the National ALS Registry.头部损伤与肌萎缩侧索硬化症：基于国家肌萎缩侧索硬化症登记处的人群研究
Brain Sci. 2025 Jan 31;15(2):143. doi: 10.3390/brainsci15020143.
10
Recent developments in consensus diagnostic criteria for amyotrophic lateral sclerosis.肌萎缩侧索硬化症共识诊断标准的最新进展。
eNeurologicalSci. 2025 Feb 1;38:100559. doi: 10.1016/j.ensci.2025.100559. eCollection 2025 Mar.